BridgeBio Oncology Therapeutics, Inc. (BBOT) stock
BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.94−0.04 (-2.02%)
Close on Nov 17, 2026Market cap $155.54MP/E –Yield –
BridgeBio Oncology Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BridgeBio Oncology Therapeutics's enterprise value was -$139.01M on Nov 11, 2026, against $506.61M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$139.01M | -126.6% |
| 2025 | Dec 31, 2025 | $523.24M | – |
See a number that looks wrong?